Gk-nav
Gk-nav has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Mar 15, 2025: “Nanovaccine loaded with seno-antigen target senescent cells to improve metabolic disorders of adipose tissue and cardiac dysfunction”.
1 paper studies it4 findingsUpdated
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Technology Development
- Animals1
What did studies of gk-nav find?
4Studies of gk-nav measured 4 outcomes, among them CD8+ T cells, cardiac dysfunction and metabolic disease.
CD8+ T cells
upin mouse cells1
1 study
CD8+ T cells
upin mouse cells1
Gk-nav activates CD8+ T cells in mouse cells (bone marrow-derived dendritic cells co-cultured in vitro).
“promoting DCs maturation and activation of CD8+T cells in vitro”
Cellsbone marrow-derived dendritic cells co-cultured in vitroself-assembled K36-Gpnmb fusion nanovaccine
Human vaccines & immunotherapeutics
Cardiac dysfunction
downin mice1
1 study
Cardiac dysfunction
downin mice1
Gk-nav decreases cardiac dysfunction in mice (high-fat diet-induced progeroid mice).
“leading to a significant improvement in age-related metabolic disorders in adipose tissue and cardiac dysfunction”
Animalshigh-fat diet-induced progeroid miceself-assembled K36-Gpnmb fusion nanovaccineheart
Human vaccines & immunotherapeutics
Metabolic disease
downin mice1
1 study
Metabolic disease
downin mice1
Gk-nav decreases metabolic disease in mice (high-fat diet-induced progeroid mice).
“leading to a significant improvement in age-related metabolic disorders in adipose tissue and cardiac dysfunction”
Animalshigh-fat diet-induced progeroid miceself-assembled K36-Gpnmb fusion nanovaccineadipose tissue
Human vaccines & immunotherapeutics
Cellular senescence
downin mice1
1 study
Cellular senescence
downin mice1
Gk-nav decreases cellular senescence in mice (high-fat diet-induced progeroid mice; nanovaccine given by subcutaneous immunization).
“the targeted anti-aging immunity triggered by GK-NaV demonstrated the ability to selectively eliminate senescent adipocytes and cardiomyocytes in high-fat diet (HFD)-induced progeroid mice”
Animalshigh-fat diet-induced progeroid mice; nanovaccine given by subcutaneous immunizationself-assembled K36-Gpnmb fusion nanovaccineadipose tissue and heart
Human vaccines & immunotherapeutics